Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by slider67on Apr 09, 2018 11:03am
132 Views
Post# 27852694

News....Strange?

News....Strange?

2018-04-09 09:18 ET - News Release

 

Mr. Jared Berry, investor, reports

JARED BERRY DISPOSES OF COMMON SHARES OF ISODIOL INTERNATIONAL INC.

Jared Berry has disposed of 4,500 common shares of Isodiol International Inc. in settlement of certain debt obligations owing by the acquirer to a third party. The issuer's head office is located at 1212 Austin Ave., Coquitlam, B.C.

On Dec. 14, 2017, the acquirer reported the ownership and control over an aggregate of 40.5 million common shares of the issuer representing approximately 16.7 per cent of the issued and outstanding common shares of the issuer on a non-diluted basis. As of the date hereof and after giving effect to the disposition, the acquirer has ownership and control over an aggregate of 40,495,500 common shares of the issuer representing approximately 13.42 per cent of the issued and outstanding common shares of the issuer on a non-diluted basis. The 4,500 subject shares were disposed of at a deemed price of approximately 88.9 cents per share for aggregate consideration of $4,000.

The subject shares were disposed of for investment purposes. The acquirer may, from time to time, directly or indirectly, take such actions in respect of his holdings in securities of the issuer, as he may deem appropriate, in light of the circumstances then existing, including the purchase of additional common shares or other securities of the issuer or the disposition of all or a portion of his securityholdings in the issuer, subject in each case to applicable securities laws and the terms of such securities.  The acquirer has the right to nominate two members of the board of directors, which right the acquirer has not exercised as of the date hereof.

Pursuant to National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, the acquirer will file an early warning report in respect of the Dispostion with the applicable Canadian securities regulators, a copy of which will be available under the issuer's profile at www.sedar.com. A copy of the early warning report can be obtained by contacting the acquirer at (951) 500-7356. Jared Berry(951) 500-7356

© 2018 Canjex Publishing Ltd. All rights reserv

Bullboard Posts